Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (281-290 of 320) with videos related to

Pageof 32
Sort By:
Cell|May 15, 2018
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian CancerAllen W Zhang, Andrew McPherson, Katy Milne, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
The Lancet. Oncology|February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesCeleste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Cancer Discovery|January 30, 2026
Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma SubtypesTomohiro Aoki, Gerben Duns, Shinya Rai, et al.
Gynecologic Oncology|July 10, 2020
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survivalKatharine K Brieger, Siri Peterson, Alice W Lee, et al.
Nature|October 26, 2022
Single-cell genomic variation induced by mutational processes in cancerTyler Funnell, Ciara H O'Flanagan, Marc J Williams, et al.
The Lancet. Oncology|August 8, 2020
Hereditary diffuse gastric cancer: updated clinical practice guidelinesVanessa R Blair, Maybelle McLeod, Fátima Carneiro, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Pageof 32

Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
Cell|May 15, 2018
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian CancerAllen W Zhang, Andrew McPherson, Katy Milne, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
The Lancet. Oncology|February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesCeleste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Cancer Discovery|January 30, 2026
Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma SubtypesTomohiro Aoki, Gerben Duns, Shinya Rai, et al.
Gynecologic Oncology|July 10, 2020
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survivalKatharine K Brieger, Siri Peterson, Alice W Lee, et al.
Nature|October 26, 2022
Single-cell genomic variation induced by mutational processes in cancerTyler Funnell, Ciara H O'Flanagan, Marc J Williams, et al.
The Lancet. Oncology|August 8, 2020
Hereditary diffuse gastric cancer: updated clinical practice guidelinesVanessa R Blair, Maybelle McLeod, Fátima Carneiro, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Pageof 32